GlaxoSmithKline wants to sell more than a third of the space at its R&D campus in Stevenage, UK, to a new bioscience cluster that it says could become one of the largest in Europe.

GlaxoSmithKline has hired computational drug design specialist Dr Kim Branson to expand its artificial intelligence and machine learning unit. Branson joins the pharma group as senior vice ...

Correspondence to Dr Paul P Tak, GlaxoSmithKline Research and Development, Stevenage SG1 2NY, UK; Paul-peter.x.tak{at}gsk.com Objectives Interleukin-6 (IL-6) is implicated in rheumatoid arthritis (RA) ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

This morning will see some patchy low cloud, mist and fog at first. This will lift through the morning to leave dry and sunny conditions for the rest of the day. A gentle to moderate easterly ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...

Are you a pre-clinical therapeutics start-up? Stevenage Bioscience Catalyst’s Catalyser programme is an accelerator designed to help businesses attract investors and partners, and maximise overall ...

Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Commences up to GBP330 million share buyback programme. Says this represents the remainder of the ...